These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties. Hughes QW; Le BT; Gilmore G; Baker RI; Veedu RN Molecules; 2017 Oct; 22(10):. PubMed ID: 29048375 [TBL] [Abstract][Full Text] [Related]
10. A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery. Nimjee SM; Keys JR; Pitoc GA; Quick G; Rusconi CP; Sullenger BA Mol Ther; 2006 Sep; 14(3):408-15. PubMed ID: 16765093 [TBL] [Abstract][Full Text] [Related]
11. Development of a novel sensing probe using DNA aptamer inhibiting enzymatic activity. Ikebukuro K; Yoshida W; Sode K Nucleic Acids Symp Ser (Oxf); 2005; (49):83-4. PubMed ID: 17150644 [TBL] [Abstract][Full Text] [Related]
12. Reversible regulation of aptamer activity with effector-responsive hairpin oligonucleotides. Li N J Lab Autom; 2013 Feb; 18(1):77-84. PubMed ID: 22651934 [TBL] [Abstract][Full Text] [Related]
14. [Comparative in vitro study of anticoagulant activity of RA36 DNA aptamer in human, rabbit, and rat blood plasma]. Savchik EIu; Kalinina TB; Drozd NN; Makarov VA; Zav'ialova EG; Lapsheva EN; Babiĭ AV; Mudrik NN; Pavlova GV; Golovin AV; Kopylov AM Eksp Klin Farmakol; 2012; 75(11):13-8. PubMed ID: 23323327 [TBL] [Abstract][Full Text] [Related]
15. In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry. Tanaka KA; Szlam F; Rusconi CP; Levy JH Thromb Haemost; 2009 May; 101(5):827-33. PubMed ID: 19404534 [TBL] [Abstract][Full Text] [Related]
16. Development of a novel DNA sensing system using DNA aptamer inhibited enzymatic activity 1. Ikebukuro K; Yoshida W; Sode K Nucleic Acids Symp Ser (Oxf); 2004; (48):231-2. PubMed ID: 17150563 [TBL] [Abstract][Full Text] [Related]
17. 4-thio-deoxyuridylate-modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix. Mendelboum Raviv S; Horváth A; Aradi J; Bagoly Z; Fazakas F; Batta Z; Muszbek L; Hársfalvi J J Thromb Haemost; 2008 Oct; 6(10):1764-71. PubMed ID: 18665927 [TBL] [Abstract][Full Text] [Related]
18. Development of a novel DNA sensing system using DNA aptamer that inhibits enzymatic activity 2. Ikebukuro K; Yoshida W; Noma T; Sode K Nucleic Acids Symp Ser (Oxf); 2004; (48):309-10. PubMed ID: 17150602 [TBL] [Abstract][Full Text] [Related]
19. Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures. Rangnekar A; Zhang AM; Li SS; Bompiani KM; Hansen MN; Gothelf KV; Sullenger BA; LaBean TH Nanomedicine; 2012 Jul; 8(5):673-81. PubMed ID: 21889476 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase. Müller J; Freitag D; Mayer G; Pötzsch B J Thromb Haemost; 2008 Dec; 6(12):2105-12. PubMed ID: 18826387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]